AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

30 recruiting trials

for Colorectal (Colon or Rectal) Cancer

The Development of MASLD Among Survivors of Breast or Colorectal Cancer NCT07280143n/a1 site📍 Bern University of Bern Fluorescence Image Guided Surgery Followed by Intraoperative Photodynamic Therapy for Improving Local Tumor Control in Patients With Locally Advanced or Recurrent Colorectal Cancer NCT06307548Phase 1, Phase 21 site📍 Buffalo Roswell Park Cancer Institute · Tests: Aminolevulinic Acid, Biospecimen Collection, Computed Tomography, Fluorescence-Guided Surgery, Magnetic Resonance Imagi… CPI-613 (Devimistat) in Combination With Hydroxychloroquine and 5-fluorouracil or Gemcitabine in Treating Patients With Advanced Chemorefractory Solid Tumors NCT05733000Phase 21 site📍 Chicago Northwestern University · Tests: Biospecimen Collection, Computed Tomography, Devimistat, Fluorouracil, Gemcitabine Hydrochloride A Study to Evaluate the Efficacy and Safety of Standard-of-Care Chemotherapy and Bevacizumab With or Without INCA33890 in the First-Line Treatment of Metastatic Microsatellite Stable Colorectal Cancer NCT07284849Phase 3293 sites📍 Mobile📍 Tucson📍 Tucson Incyte Corporation · Tests: INCA33890, Placebo, Bevacizumab, FOLFOX A Study to Learn About the Study Medicine Called PF-08032562 in People With Advanced or Metastatic Solid Tumors NCT07318805Phase 113 sites📍 Duarte📍 Grand Rapids📍 Long Island City Pfizer · Tests: PF-08032562, Fulvestrant, Cetuximab, Fluorouracil, Oxaliplatin Biological Tumor Infiltrating Lymphocytes Therapy With Immunotherapy for Colon and Rectum Cancer NCT06530303Phase 1, Phase 21 site📍 Beijing Essen Biotech · Tests: Tumor Infiltrating Lymphocytes (TIL), Cyclophosphamide, Fludarabine, Interleukin-2, Pembrolizumab AMG 410 Alone and in Combination With Other Agents in Participants With KRAS Altered Advanced or Metastatic Solid Tumors NCT07094113Phase 139 sites📍 Duarte📍 Los Angeles📍 Atlanta Amgen · Tests: AMG 410, Pembrolizumab, Panitumumab Colorectal Cancer Screnning Colonoscopy Under Hypnosis NCT05051046NA1 site📍 Angers University Hospital, Tours · Tests: Colonoscopy under hypnosis The Safety and Efficacy of Cetuximab Beta Plus Fruquintinib With or Without Immune Checkpoint Inhibitorrs in First-line Treatment of RAS/BRAF Wild Type Unresectable Metastatic Colorectal Cancer NCT07257653Phase 21 site📍 Hangzhou Zhejiang University · Tests: Cetuximab β;Fruquintinib;, Cetuximab β;Fruquintinib;anti-PD1 antibody;, Cetuximab β;Fruquintinib;anti-PD1/CTLA4 antibody A Study of PT0511 in Participants With KRAS Mutated or Amplified Advanced Solid Tumors NCT07300150Phase 19 sites📍 Boston📍 San Antonio📍 San Antonio PAQ Therapeutics, Inc. · Tests: PT0511, Cetuximab Stereotactic Ablative Radiotherapy (SABR) for the Treatment of Patients With Metastatic Cancer, ID-COMET Trial NCT06563388Phase 31 site📍 Buffalo Roswell Park Cancer Institute · Tests: Stereotactic Ablative Radiotherapy, Best Practice CT-95 in Advanced Cancers Associated With Mesothelin Expression NCT06756035Phase 19 sites📍 Denver📍 Chicago📍 Grand Rapids Context Therapeutics Inc. · Tests: CT-95 Avapritinib for the Treatment of CKIT or PDGFRA Mutation-Positive Locally Advanced or Metastatic Malignant Solid Tumors NCT04771520Phase 21 site📍 Houston M.D. Anderson Cancer Center · Tests: Avapritinib Open-label Phase 1b Study of Ulixertinib and Cetuximab or Ulixertinib in Combination With Cetuximab and Encorafenib in Patients With Unresectable or Metastatic Colorectal Cancer Who Have Previously Received EGFR or BRAF-directed Therapy NCT05985954Phase 11 site📍 Houston M.D. Anderson Cancer Center · Tests: Cetuximab, Ulixertinib, Encorafenib Study of MT-302 in Adults With Advanced or Metastatic Epithelial Tumors NCT05969041Phase 16 sites📍 Darlinghurst📍 Randwick📍 Westmead Myeloid Therapeutics · Tests: MT-302 (A) Efficacy and Safety of Retlirafusp Alfa Plus Bevacizumab and Chemotherapy With or Without Short-Course Radiotherapy in Patients With CRCLM NCT07728019Phase 21 site📍 Wuhan Union Hospital, Tongji Medical College, Huazhong University… · Tests: SCRT, Retlirafusp alfa Injection, Bevacizumab, CAPOX Spevatamig (PT886) as Monotherapy or in Combination With Chemo and/or Targeted Therapy and/or ICI, for the Treatment of Patients With Advanced Gastrointestinal Cancers, Including Gastric, Gastroesophageal Junction, Pancreatic Ductal or Biliary Tract Carcinomas (the TWINPEAK Study) NCT05482893Phase 1, Phase 211 sites📍 Duarte📍 Los Angeles📍 Denver Phanes Therapeutics · Tests: Spevatamig (PT886), Paclitaxel, Gemcitabine, Abraxane, KEYTRUDA® (pembrolizumab) Clinical Trial Evaluating the Activity of Zanidatamab for the Treatment of Patients With Solid Tumors With an Alteration of the HER2 Gene. NCT07192068Phase 24 sites📍 Angers📍 Marseille📍 Vandœuvre-lès-Nancy UNICANCER · Tests: Zanidatamab Adjuvant FOLFIRI Based-chemotherapy After Resection of CLM Responding to Preoperative FOLFIRI NCT06501482Phase 31 site📍 Paris Assistance Publique - Hôpitaux de Paris · Tests: Postoperative reintroduction of FOLFIRI based chemotherapy LYL273 for Patients With Relapsed or Refractory mCRC NCT05319314Phase 1, Phase 25 sites📍 Duarte📍 San Francisco📍 Aurora Lyell Immunopharma, Inc. · Tests: LYL273 Perioperative Biomarkers in Colorectal and Gastric Cancer Surgery NCT07881133NA1 site📍 Bucharest Bucharest Emergency Hospital · Tests: Perioperative Biomarker-Guided Monitoring mFOLFOX6 + Bevacizumab + PD-1 Monoclonal Antibody Vs. mFOLFOX6 in Locally Advanced pMMR/MSS CRC NCT06791512Phase 31 site📍 Guangzhou Jun Huang · Tests: mFOLFOX6 + Bevacizumab + PD-1 monoclonal antibody, mFOLFOX6 Clonal Hematopoiesis Chemotherapy and Radiation Effects Study NCT07675967n/a1 site📍 Boston Dana-Farber Cancer Institute · Tests: Samples Study of Sotorasib, Panitumumab and FOLFIRI Versus FOLFIRI With or Without Bevacizumab-awwb in Treatment-naïve Participants With Metastatic Colorectal Cancer With KRAS p.G12C Mutation NCT06252649Phase 3291 sites📍 Chandler📍 Fullerton📍 Long Beach Amgen · Tests: FOLFIRI Regimen, Sotorasib, Panitumumab, Bevacizumab-awwb Obtaining Solid Tumor Tissue From People Having Biopsy or Surgery for Certain Types of Cancer NCT01915225n/a1 site📍 Bethesda National Cancer Institute (NCI) Trifluridine/Tipiracil and Talazoparib for the Treatment of Patients With Locally Advanced or Metastatic Colorectal or Gastroesophageal Cancer NCT04511039Phase 11 site📍 Buffalo Roswell Park Cancer Institute · Tests: Trifluridine and Tipiracil Hydrochloride, Talazoparib Tosylate Engineered TILs/CAR-TILs to Treat Advanced Solid Tumors NCT04842812Phase 11 site📍 Guangzhou Second Affiliated Hospital of Guangzhou Medical University · Tests: TILs and CAR-TILs targeting HER2, Mesothelin, PSCA, MUC1, Lewis-Y, GPC3, AXL, EGFR, Claudin18.2/6, ROR1, GD1, or B7-H3 A Study to Evaluate Safety and Efficacy of BEY1107 in Combination with Capecitabine in Patients with Metastatic Colorectal Cancer NCT05093907Phase 1, Phase 21 site📍 Seoul BeyondBio Inc. · Tests: BEY1107, Capecitabine A Phase II Study of AMT-676 Combination Therapies in Advanced Colorectal Cancer NCT07474727Phase 219 sites📍 Fuzhou📍 Nanning📍 Guangzhou Multitude Therapeutics Inc. · Tests: AMT-676, 5-FU, Leucovorin, Bevacizumab, Cetuximab Utero-ovarian Transposition in Patients With Pelvic Malignancies Undergoing Whole Pelvic Radiotherapy NCT07419490NA1 site📍 Tampa University of South Florida · Tests: Uteroovarian transposition
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy